Ikuko Kakizaki

Ikuko Kakizaki

Auto-generated profile, based on publicly available information

Ikuko Kakizaki

Department of Glycotechnology, Center for Advanced Medical Research, Hirosaki University Graduate School of Medicine

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
IKIkuko Kakizaki
Ikuko Kakizaki
KKKaoru Kojima
Kaoru Kojima
KTKeiichi Takagaki
Keiichi Takagaki
MEMasahiko Endo
Masahiko Endo
RKReiji Kannagi
Reiji Kannagi
NINaoki Itano
Naoki Itano
Specific inhibitors of hyaluronan (HA) biosynthesis can be valuable therapeutic agents to prevent cancer invasion and metastasis. We have found previously that 4-methylumbelliferone (MU) inhibits HA synthesis in human skin fibroblasts and in group C Streptococcus. In this paper, the inhibition mechanism in mammalian cells was investigated using rat 3Y1 fibroblasts stably expressing HA synthase (HAS) 2. Exposure of the transfectants to the inhibitor resulted in significant reduction of HA biosynthesis and matrix formation. The evaluation of HAS transcripts and analysis of cell-free HA synthesis demonstrated the post-transcriptional suppression of HAS activity by MU. Most interesting, the post-transcriptional suppression of HAS activity was also observed using p-nitrophenol, a well known substrate for UDP-glucuronyltransferases (UGT). We investigated whether the inhibition was exerted by the glucuronidation of MU using both high pressure liquid chromatography and TLC analyses. The production of MU-glucuronic acid (GlcUA) was consistent with the inhibition of HA synthesis in HAS transfectants. MU-GlcUA was also detected at a similar level in control cells, suggesting that the glucuronidation was mediated by an endogenous UGT. Elevated levels of UGT significantly enhanced the inhibitory effects of MU. In contrast, the inhibition by MU was diminished to the control level when an excess of UDP-GlcUA was added to the cell-free HA synthesis system. We propose a novel mechanism for the MU-mediated inhibition of HA synthesis involving the glucuronidation of MU by endogenous UGT resulting in a depletion of UDP-GlcUA.

9 April 2005 in FEBS Letters
Verified
Journal Article
Closed access
SYShuichi Yoshihara
Shuichi Yoshihara
AKAtsushi Kon
Atsushi Kon
DKDaisuke Kudo
Daisuke Kudo
HNHideaki Nakazawa
Hideaki Nakazawa
IKIkuko Kakizaki
Ikuko Kakizaki
KTKeiichi Takagaki
Keiichi Takagaki

15 September 2005 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
HNHideaki Nakazawa
Hideaki Nakazawa
SYShuichi Yoshihara
Shuichi Yoshihara
DKDaisuke Kudo
Daisuke Kudo
HMHajime Morohashi
Hajime Morohashi
IKIkuko Kakizaki
Ikuko Kakizaki
MSMutsuo Sasaki
Mutsuo Sasaki

1 November 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TCTheerawut Chanmee
Theerawut Chanmee
POPawared Ontong
Pawared Ontong
TITomomi Izumikawa
Tomomi Izumikawa
MHMiho Higashide
Miho Higashide
NMNobutoshi Mochizuki
Nobutoshi Mochizuki
NINaoki Itano
Naoki Itano
Cancer stem cells (CSCs) represent a small subpopulation of self-renewing oncogenic cells. As in many other stem cells, metabolic reprogramming has been implicated to be a key characteristic of CSCs. However, little is known about how the metabolic features of cancer cells are controlled to orchestrate their CSC-like properties. We recently demonstrated that hyaluronan (HA) overproduction allowed plastic cancer cells to revert to stem cell states. Here, we adopted stable isotope-assisted tracing and mass spectrometry profiling to elucidate the metabolic features of HA-overproducing breast cancer cells. These integrated approaches disclosed an acceleration of metabolic flux in the hexosamine biosynthetic pathway (HBP). A metabolic shift toward glycolysis was also evident by quantitative targeted metabolomics, which was validated by the expression profiles of key glycolytic enzymes. Forced expression of glutamine:fructose-6-phosphate amidotransferase 1 (GFAT1), an HBP rate-limiting enzyme, resembled the results of HA overproduction with regard to HIF-1α accumulation and glycolytic program, whereas GFAT1 inhibition significantly decreased HIF-1α protein level in HA-overproducing cancer cells. Moreover, inhibition of the HBP-HIF-1 axis abrogated HA-driven glycolytic enhancement and reduced the CSC-like subpopulation. Taken together, our results provide compelling evidence that HA production regulates the metabolic and CSC-like properties of breast cancer cells via HBP-coupled HIF-1 signaling.

1 June 2002 in Biochemical Journal
Verified
Journal Article
Closed access
HIHiromi Ikeda
Hiromi Ikeda
MSMohamed S. Serria
Mohamed S. Serria
IKIkuko Kakizaki
Ikuko Kakizaki
IHIchiro Hatayama
Ichiro Hatayama
KSKimihiko Satoh
Kimihiko Satoh
MSMasaharu Sakai
Masaharu Sakai
The Pi-class glutathione S-transferases (GSTs) play pivotal roles in the detoxification of xenobiotics, carcinogenesis and drug resistance. The mechanisms of regulation of these genes during drug induction and carcinogenesis are yet to be elucidated. Recently, Nrf2 (NF-E2-related factor 2; a bZip-type transcription factor) knockout mice were shown to display impaired induction of Pi-class GST genes by drugs. It is known that the mouse Pi-class GST gene GST-P1 is expressed predominantly in the male liver, and is regulated by androgen. To determine whether Nrf2 and the androgen receptor regulate GST-P1 directly, we analysed the molecular mechanism of activation of this gene by these factors. The promoter of the GST-P1 gene was activated markedly by Nrf2 in transient transfection analyses. Gel mobility shift assay and footprinting analyses revealed three Nrf2 binding sites: one at the proximal and two at distal elements, located at positions −59, −915 and −937 from the cap site. The fifth intron of the GST-P1 gene contains the androgen-responsive region. Multiple androgen receptor binding sites are clustered within a 500bp region of this intron. The whole fragment contains a minimum of seven androgen receptor binding sites, which collectively display strong androgen-dependent enhancer activity. However, on division into small fragments containing two or three elements each, individual enhancer activities were dramatically decreased. This suggests that multiple elements work synergistically as a strong androgen-responsive enhancer. Our findings indicate that Nrf2 and the androgen receptor directly bind to and activate the mouse GST-P1 gene.

6 February 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
DMD. C. Ghislaine Mayer
D. C. Ghislaine Mayer
LJLubin Jiang
Lubin Jiang
RARajeshwara Achur
Rajeshwara Achur
IKIkuko Kakizaki
Ikuko Kakizaki
DGD. Channe Gowda
D. Channe Gowda
LMLouis H Miller
Louis H Miller
Plasmodium vivax uses a single member of the Duffy binding-like (DBL) receptor family to invade erythrocytes and is not found in West Africa where its erythrocyte ligand, the Duffy blood group antigen, is missing. In contrast, Plasmodium falciparum expresses four members of the DBL family, and remarkably, single-point mutations of two of these receptors (BAEBL and JESEBL) bind to entirely different erythrocyte ligands, greatly expanding the range of erythrocytes that P. falciparum can invade. In this article, we describe the molecular basis of the binding specificity for one BAEBL variant (VSTK) that binds to glycophorin C. We demonstrate that soluble glycophorin C completely blocks the binding of BAEBL (VSTK) to human erythrocytes, requiring 0.7 μM for 50% inhibition, a concentration similar to that required by glycophorin A to block the binding of erythrocyte-binding antigen 175 to erythrocytes. BAEBL (VSTK) does not bind to Gerbich-negative erythrocytes that express a truncated form of glycophorin C because it lacks exon 3. The N-linked oligosaccharide of Gerbich-negative glycophorin C has a markedly different composition than the wild-type glycophorin C. Moreover, removal of the N-linked oligosaccharide from the wild-type glycophorin C eliminates its ability to inhibit binding of BAEBL (VSTK) to erythrocytes. These findings are consistent with the ligand for BAEBL (VSTK) being, in part, the N-linked oligosaccharide and suggest that single-point mutations in BAEBL allow P. falciparum to recognize oligosaccharides on different erythrocyte surface glycoproteins or glycolipids, greatly increasing its invasion range.